Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing

被引:150
作者
Placencio, Veronica R. [1 ,2 ]
DeClerck, Yves A. [1 ,2 ,3 ]
机构
[1] Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Bone Marrow Transplan, Los Angeles, CA 90089 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[3] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
FIBROSARCOMA CELLS; PAI-1; INHIBITOR; BREAST-CANCER; TUMOR-GROWTH; WILD-TYPE; UROKINASE; TYPE-1; ANGIOGENESIS; DEFICIENT; BINDING;
D O I
10.1158/0008-5472.CAN-15-0876
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite its function as an inhibitor of urokinase and tissue-type plasminogen activator (PA), PA inhibitor-1 (PAI-1) has a paradoxical protumorigenic role in cancer, promoting angiogenesis and tumor cell survival. In this review, we summarize preclinical evidence in support of the protumorigenic function of PAI-1 that has led to the testing of small-molecule PAI-1 inhibitors, initially developed as antithrombotic agents, in animal models of cancer. The review discusses the challenges and the opportunities that lay ahead to the development of efficacious and nontoxic PAI-1 inhibitors as anticancer agents. (C) 2015 AACR.
引用
收藏
页码:2969 / 2974
页数:6
相关论文
共 50 条
[21]   USE OF MOUSE MODELS TO STUDY PLASMINOGEN ACTIVATOR INHIBITOR-1 [J].
Declerck, Paul J. ;
Gils, Ann ;
De Taeye, Bart .
METHODS IN ENZYMOLOGY: BIOLOGY OF SERPINS, 2011, 499 :77-104
[22]   Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin [J].
Luo, M. ;
Ji, Y. ;
Luo, Y. ;
Li, R. ;
Fay, W. P. ;
Wu, J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (12) :2451-2460
[23]   Thrombomodulin and Plasminogen Activator Inhibitor-1 Expression in Recurrent Miscarriages [J].
Papamitsou, Theodora ;
Toskas, Alexandros ;
Papadopoulo, Kyriaki ;
Economou, Zinon ;
Sioga, Antonia .
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2016, 38 (06) :350-356
[24]   Design and synthesis of oxadiazolidinediones as inhibitors of plasminogen activator inhibitor-1 [J].
Gopalsamy, A ;
Kincaid, SL ;
Ellingboe, JW ;
Groeling, TM ;
Antrilli, TM ;
Krishnamurthy, G ;
Aulabaugh, A ;
Friedrichs, GS ;
Crandall, DL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) :3477-3480
[25]   Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis [J].
Alotaibi, Fahad T. ;
Peng, Bo ;
Klausen, Christian ;
Lee, Anna F. ;
Abdelkareem, Amr O. ;
Orr, Natasha L. ;
Noga, Heather ;
Bedaiwy, Mohamed A. ;
Yong, Paul J. .
PLOS ONE, 2019, 14 (07)
[26]   Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer? [J].
Sotiropoulos, George P. ;
Kotopouli, Marianna ;
Karampela, Irene ;
Christodoulatos, Gerasimos-Socrates ;
Antonakos, Georgios ;
Marinou, Ioanna ;
Vogiatzakis, Evaggelos ;
Lekka, Antigoni ;
Papavassiliou, Athanasios G. ;
Dalamaga, Maria .
JOURNAL OF BUON, 2019, 24 (03) :943-954
[27]   Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer [J].
Gillespie, Earl ;
Leeman, Susan E. ;
Watts, Luisa A. ;
Coukos, Jennifer A. ;
O'Brien, Michael J. ;
Cerda, Sandra R. ;
Farraye, Francis A. ;
Stucchi, Arthur F. .
JOURNAL OF CROHNS & COLITIS, 2013, 7 (05) :403-411
[28]   Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells [J].
Kang, JiHoon ;
Kim, Wanyeon ;
Kwon, TaeWoo ;
Youn, HyeSook ;
Kim, Joong Sun ;
Youn, BuHyun .
ONCOTARGET, 2016, 7 (17) :23961-23974
[29]   Characterization of a Novel Class of Polyphenolic Inhibitors of Plasminogen Activator Inhibitor-1 [J].
Cale, Jacqueline M. ;
Li, Shih-Hon ;
Warnock, Mark ;
Su, Enming J. ;
North, Paul R. ;
Sanders, Karen L. ;
Puscau, Maria M. ;
Emal, Cory D. ;
Lawrence, Daniel A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) :7892-7902
[30]   Urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor-1: New functional risk factors in head and neck squamous cell cancer [J].
Wollenberg, B ;
Jan, NV ;
Jund, R ;
Chaubal, S ;
Untch, M .
ONCOLOGY REPORTS, 1997, 4 (04) :853-855